Literature DB >> 34021216

Gene variants and expression changes of SIRT1 and SIRT6 in peripheral blood are associated with Parkinson's disease.

Rita Maszlag-Török1, Fanni A Boros1, László Vécsei1,2, Péter Klivényi3.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disease caused by complex interaction between genetic and environmental factors. There is a growing body of evidence of the involvement of sirtuins (SIRTs) in disease pathomechanism. SIRTs are NAD+-dependent histone deacetylases which take part in various cellular functions. However, available data of the relationship between SIRT gene polymorphisms and PD is limited. Our aim was to investigate the possible association of 10 SNPs identified within non-mitochondrial SIRTs, SIRT1, -2 and -6 with the risk of PD in Hungarian population, and to compare the expression level of these SIRTs between healthy controls and PD patients. Our results showed that rs3740051 and rs3818292 of SIRT1 and rs350843, rs350844, rs107251, rs350845 and rs350846 of SIRT6 show weak association with PD risk. On the contrary rs12778366 and rs3758391 of SIRT1 and rs10410544 of SIRT2 did not show association with PD. Moreover, we detected that mRNA level of SIRT1 was down-regulated, and mRNA level of SIRT6 was up-regulated, while SIRT2 mRNA level was not altered in the peripheral blood of PD patients as compared to controls. The difference in both cases was more pronounced when comparing the early-onset PD group to the control cohort. Nevertheless, mRNA level changes did not show any association with the presence of any of the investigated SNPs either in the PD or in the control group. In conclusion, our findings suggest that non-mitochondrial sirtuins, SIRT1 and -6 but not SIRT2 might contribute to the pathogenesis of PD in the Hungarian population both via their altered mRNA levels and via gene alterations identified as specific SNPs.

Entities:  

Year:  2021        PMID: 34021216     DOI: 10.1038/s41598-021-90059-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  38 in total

Review 1.  Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease.

Authors:  Lena F Burbulla; Rejko Krüger
Journal:  J Neurol Sci       Date:  2011-04-21       Impact factor: 3.181

2.  Mitochondrial sirtuins as therapeutic targets for age-related disorders.

Authors:  Jennifer Shih; Gizem Donmez
Journal:  Genes Cancer       Date:  2013-03

3.  Resveratrol synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson disease in mice.

Authors:  Qianqian Liu; Dashuai Zhu; Peien Jiang; Xinyu Tang; Qiuhan Lang; Qinyi Yu; Shaozhi Zhang; Yongzhe Che; Xizeng Feng
Journal:  Behav Brain Res       Date:  2019-03-25       Impact factor: 3.332

4.  SIRT1 protects against α-synuclein aggregation by activating molecular chaperones.

Authors:  Gizem Donmez; Anirudh Arun; Chee-Yeun Chung; Pamela J McLean; Susan Lindquist; Leonard Guarente
Journal:  J Neurosci       Date:  2012-01-04       Impact factor: 6.167

5.  Cdk5 suppression blocks SIRT1 degradation via the ubiquitin-proteasome pathway in Parkinson's disease models.

Authors:  Qian Zhang; Pei Zhang; Guang-Jian Qi; Zheng Zhang; Feng He; Ze-Xi Lv; Xiang Peng; Hong-Wei Cai; Tong-Xia Li; Xue-Min Wang; Bo Tian
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-03-21       Impact factor: 3.770

6.  Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses.

Authors:  Dario D Lofrumento; Giuseppe Nicolardi; Antonia Cianciulli; Francesco De Nuccio; Velia La Pesa; Vito Carofiglio; Teresa Dragone; Rosa Calvello; Maria A Panaro
Journal:  Innate Immun       Date:  2013-06-13       Impact factor: 2.680

7.  Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.

Authors:  Feng Jin; Qin Wu; Yuan-Fu Lu; Qi-Hai Gong; Jing-Shan Shi
Journal:  Eur J Pharmacol       Date:  2008-10-10       Impact factor: 4.432

Review 8.  Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders.

Authors:  Henryk Jęśko; Przemysław Wencel; Robert P Strosznajder; Joanna B Strosznajder
Journal:  Neurochem Res       Date:  2016-11-24       Impact factor: 3.996

Review 9.  Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View.

Authors:  Giovanna Cenini; Ana Lloret; Roberta Cascella
Journal:  Oxid Med Cell Longev       Date:  2019-05-09       Impact factor: 6.543

Review 10.  Sirtuins in neurodegenerative diseases: an update on potential mechanisms.

Authors:  Sang-Won Min; Peter D Sohn; Seo-Hyun Cho; Raymond A Swanson; Li Gan
Journal:  Front Aging Neurosci       Date:  2013-09-25       Impact factor: 5.750

View more
  1 in total

Review 1.  NAD+ Metabolism and Diseases with Motor Dysfunction.

Authors:  Samuel Lundt; Shinghua Ding
Journal:  Genes (Basel)       Date:  2021-11-09       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.